ArcticZymes said last week that it has inked a supply agreement with GE Healthcare Life Sciences for products based on ArcticZymes' portfolio of heat-labile enzymes.

Tromsø, Norway-based ArcticZymes' heat-labile enzyme portfolio includes shrimp alkaline phosphatase, Cod-UNG, DNases and other nucleases, and kits for PCR decontamination and genomic DNA removal. The cold-adapted enzymes are particularly well-suited for molecular biology research and diagnostic applications, ArcticZymes said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.